February 2022 News & Views: Stay Ahead of the Curve at AMCP 2022; AMCP to Hold First Health Disparities Summit June 9; Consequences of Putting a Band-Aid on a Virus; Tune Into the 2022 Policy Outlook Webinar On-Demand; AMCP Launches New Affiliate, AMCP Carolinas.
On Feb. 14, AMCP joined a pharmacy stakeholder letter supporting Dr. Robert Califf's nomination for FDA Commissioner, a post he previously held in 2016.
On Feb. 9, AMCP submitted comments to CMS supporting the agency's proposal to cover anti-amyloid monoclonal antibodies through the Coverage with Evidence Development pathway.
AMCP recently caught up with Todd Hood, senior director of national accounts at Spero Therapeutics, Inc., to learn about the company and gain insights on becoming an AMCP Corporate Member.
On Jan. 11, CMS released a proposed coverage decision that would cover the costs of monoclonal antibody treatments for Alzheimer's Disease patients only if they are enrolled in clinical trials.